References
- Bladen, C., Hamid, J., Souza, I., & Zamponi, G. W. (2014). Block of T-type calcium channels by protoxins I and II. Molecular Brain, 7, 1–8.
- Deuis, J., Wingerd, J., Winter, Z., Durek, T., Sousa, S., Zimmermann, K., … Vetter, I. (2016). Analgesic effects of GpTx-1, PF-04856264 and CNV1014802 in a mouse model of Nav1.7-mediated pain. Toxins, 8, 1–19.
- Edgerton, G., Blumenthal, K., & Hanck, D. (2010). Inhibition of the activation pathway of the T-type calcium channel CaV3.1 by ProTxII. Toxicon Official Journal of the International Society on Toxinology, 56, 624–636.10.1016/j.toxicon.2010.06.009
- Edgerton, G., Blumenthal, K., & Hanck, D. (2011). Evidence for multiple effects of ProTxII on activation gating in NaV1.5. Toxicon Official Journal of the International Society on Toxinology, 52, 489–500.
- Eshaghi, S., Hedrén, M., Nasser, M., Hammarberg, T., Thornell, A., & Nordlund, P. (2005). An efficient strategy for high-throughput expression screening of recombinant integral membrane proteins. Protein Science, 14, 676–683.10.1110/ps.041127005
- Klint, J., Senff, S., Rupasinghe, D., Er, S., Nicholson, G., & King, G. (2012). Spider-venom peptides that target voltage-gated sodium channels: Pharmacological tools and potential therapeutic leads. Toxicon, 60, 478–491.10.1016/j.toxicon.2012.04.337
- Kolmar, H. (2010). Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins. Current Opinion in Pharmacology, 41, 608–614.
- Kozlov, S. (2007). Polypeptide toxins from animal venoms. Recent Patents on DNA & Gene Sequences, 1, 200–206.10.2174/187221507782360254
- Meng, E., Cai, T., Li, W., Zhang, H., Liu, Y., Peng, K., … Zhang, D. (2011). Functional expression of spider neurotoxic peptide huwentoxin-I in E. coli. PLoS ONE, 6, 1–6.
- Ono, S., Kimura, T., & Kubo, T. (2011). Characterization of voltage-dependent calcium channel blocking peptides from the venom of the tarantula Grammostola rosea. Toxicon Official Journal of the International Society on Toxinology, 58, 265–276.10.1016/j.toxicon.2011.06.006
- Richard, E., Vivien, A., Richard, L., Jeremy, C., Chou, J., Ge, D., … Mchardy, M. (2002). Two tarantula peptides inhibit activation of multiple sodium channels. Biochemistry, 41, 14734–14747.
- Saez, N., Senff, S., Jensen, J., Sing, Er., Herzig, V., Rash, L., & King, G. (2010). Spider-venom peptides as therapeutics. Toxins, 2, 2851–2871.
- Salari, A., Vega, B., Milescu, L., & Milescu, L. (2016). Molecular interactions between tarantula toxins and low-voltage-activated calcium channels. Scientific Reports, 6, 1–12.
- Schmalhofer, W., Calhoun, J., Burrows, R., Bailey, T., Kohler, M., Kaczorowski, G., … Priest, B. (2008). ProTx-II, a selective inhibitor of Nav1.7 sodium channels, blocks action potential propagation in nociceptors. Molecular Pharmacology, 74, 1476–1484.10.1124/mol.108.047670
- Smith, J., Alphy, S., Seibert, A., Seibert, A., & Blumenthal, M. (2005). Differential phospholipid binding by site 3 and site 4 toxins. Journal of Biological Chemistry, 280, 11127–11133.10.1074/jbc.M412552200
- Smith, J., Cummins, T., Alphy, S., & Blumenthal, K. (2007). Molecular interactions of the gating modifier toxin ProTx-II with Nav1.5: Implied existence of a novel toxin binding site coupled to activation. Journal of Biological Chemistry, 282, 12687–12697.10.1074/jbc.M610462200
- Studier, F. (2005). Protein production by auto-induction in high density shaking cultures. Protein Expression & Purification, 41, 207–234.10.1016/j.pep.2005.01.016
- Van, D., & Löwe, J. (2006). RF cloning: A restriction-free method for inserting target genes into plasmids. Journal of Biochemical & Biophysical Methods, 67, 67–74.
- Wu, H., Chen, B., Jiang, H., Wu, L., Zhu, L., Meng, E., & Zhang, D. (2016). Heterologous expression and purification of neurotoxic hainantoxin-III in E. coli. Preparative Biochemistry & Biotechnology, 47, 158–162.
- Xiao, Y., Blumenthal, K., Jackson, J., Liang, S., & Cummins, T. (2010). The tarantula toxins ProTx-II and Huwentoxin-IV differentially interact with human Nav1.7 voltage sensors to inhibit channel activation and inactivation. Molecular Pharmacology, 78, 1124–1134.10.1124/mol.110.066332
- Zhang, H., Huang, P., Meng, E., Li, W., Zhou, L., Zhu, L., … Zhang, D. (2015). An efficient strategy for heterologous expression and purification of active peptide hainantoxin-IV. PLoS ONE, 10, 1–13.